Healthcare

Sarepta Therapeutics finds itself navigating significant regulatory challenges as the U.S. Food and Drug Administration has imposed the most serious...

Shares of Abbott Laboratories experienced significant volatility following the announcement of a major acquisition in the cancer diagnostics sector. The...

The telehealth provider Hims & Hers has unveiled a substantial new capital return initiative, authorizing a share buyback program valued...

The US healthcare behemoth is currently facing one of the most tumultuous periods in its corporate history. A tragic death...

While retail investors remain cautious, major financial institutions are demonstrating growing confidence in UnitedHealth Group. Recent portfolio disclosures reveal that...

Cross Country Healthcare finds itself navigating turbulent waters as its proposed acquisition by Aya Healthcare faces mounting skepticism from investors....

The equity story for Hims & Hers is currently defined by a dramatic clash between persistent market anxieties and emerging...

In a surprising strategic pivot, Medical Properties Trust has launched an aggressive campaign to restore market confidence through dividend growth...

Speculative investors in InnoCan Pharma received the news they've been anticipating, with groundbreaking research data potentially paving the way for...

Contact lens specialist Cooper Companies finds itself navigating turbulent waters after delivering a shocking forecast revision that sent its shares...